CSF3 and Opportunistic infection: Current therapeutic strategies used for patients with X-HIGM include HSCT, immunoglobulin replacement, granulocyte colony-stimulating factor (G-CSF) administration, and antimicrobial prophylaxis for opportunistic infections [36].